Disease: Epidermolysis bullosa
- "Quality of Life in Epidermolysis Bullosa" and "Epidermolysis Bullosa Burden of Disease": Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires
- A case of dystrophic epidermolysis bullosa with a rare COL7A1 variant
- A case of epidermolysis bullosa pruriginosa with a COL7A1 gene mutation successfully treated with upadacitinib
- A case of intermediate recessive dystrophic epidermolysis bullosa with a novel COL7A1 mutation
- A patient with concomitant epidermolysis bullosa acquisita, acquired hemophilia and disseminated warts
- Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa-Associated Cutaneous Squamous Cell Carcinoma
- Advanced gene-editing strategy for epidermolysis bullosa simplex
- Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy
- Advantages of whole-exome sequencing over immunomapping in 67 Brazilian patients with epidermolysis bullosa
- An unusual cause of inguinal ulceration - dystrophic epidermolysis bullosa
- Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa
- Bart syndrome: A case report of neonatal disorder
- Battling a rarity: A case of kindler syndrome from a developing country
- Beyond the Surface: A Narrative Review Examining the Systemic Impacts of Recessive Dystrophic Epidermolysis Bullosa
- Biology of Pellino1: a potential therapeutic target for inflammation in diseases and cancers
- Bone marrow transplantation and bone marrow-derived mesenchymal stem cell therapy in epidermolysis bullosa: A systematic review
- Cancer-associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma
- Caring for babies born with epidermolysis bullosa
- Challenges and progress related to gene editing in rare skin diseases
- Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study
- Clinical phenotype of the PIK3R1-related vascular overgrowth syndrome
- Clinical-grade human skin-derived ABCB5+ mesenchymal stromal cells exert anti-apoptotic and anti-inflammatory effects <em>in vitro</em> and modulate mRNA expression in a cisplatin-induced kidney injury murine model
- Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus
- Cost of hospitalization for care of children with Epidermolysis Bullosa in the US
- Costs of UK community care for individuals with recessive dystrophic epidermolysis bullosa: Findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study
- Cyclization-enhanced poly(β-amino ester)s vectors for efficient CRISPR gene editing therapy
- Dental implant survival in epidermolysis bullosa patients: A systematic review conducted according to PRISMA guidelines and the Cochrane handbook for systematic reviews of interventions
- Dipeptidyl peptidase-4-mediated fibronectin processing evokes a pro-fibrotic extracellular matrix
- Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ Th2 cells which may contribute to pruritus in lesional skin
- Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant Treatment
- Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
- Dystrophic epidermolysis bullosa: from disease biology to biologic therapy
- Dystrophic epidermolysis with dilation of esophageal stricture: A case report
- EBS in Children with De Novo Pathogenic Variants Disturbing <em>Krt14</em>
- Eine Patientin mit gleichzeitiger Epidermolysis bullosa acquisita, erworbener Hämophilie und disseminierten Warzen: A patient with concomitant epidermolysis bullosa acquisita, acquired hemophilia and disseminated warts
- Elevated expression of interleukin-6 (IL-6) and serum amyloid A (SAA) in the skin and the serum of recessive dystrophic epidermolysis bullosa: Skin as a possible source of IL-6 through Toll-like receptor ligands and SAA
- Emerging Gene Therapeutics for Epidermolysis Bullosa under Development
- En Route to Targeted Ribosome Editing to Replenish Skin Anchor Protein LAMB3 in Junctional Epidermolysis Bullosa
- Epidemiological Assessment of a Pediatric Palliative Care Clinic at a Brazilian Quaternary Hospital: 20 Years of Experience
- Epidermolysis Bullosa: Practical Clinical Tips From the Field
- Epidermolysis Bullosa: Two rare case reports of COL7A1 and EBS-GEN SEV KRT14 variants with review of literature
- Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for Immunotherapy
- Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa
- Evolution of genome diagnostics in epidermolysis bullosa: Unveiling the power of next-generation sequencing
- Experience of dupilumab treatment in inherited epidermolysis bullosa: a short series
- Gamma-secretase inhibitors down-regulate the pro-fibrotic Notch signaling pathway in recessive dystrophic epidermolysis bullosa
- Gene-edited cells: novel allogeneic gene/cell therapy for epidermolysis bullosa
- Hereditary epidermolysis bullosa: clinical-epidemiological profile of 278 patients at a tertiary hospital in Sao Paulo, Brazil
- Human-Induced Pluripotent Stem Cells in Plastic and Reconstructive Surgery
- Identification of novel KRT5 gene variants in two Chinese patients with sporadic form of epidermolysis bullosa simplex: A case report
- IgM-mediated epidermolysis bullosa acquisita
- IL-6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: A prospective cohort study
- Immune-mediated oral mucosal pathology: a comprehensive review and update for clinicians - part II
- Increased Mortality Risk at Septic Condition in Inflammatory Skin Disorders and the Effect of High-Fat Diet Consumption
- Induced pluripotent stem cell (iPSC) line MLi005-A derived from a patient with dominant dystrophic epidermolysis bullosa (DDEB)
- Inpatient Management of Epidermolysis Bullosa: Consensus-Based Hands-On Instructions for Neonates and Post-Neonates
- Integrin α3 mutation junctional epidermolysis bullosa presenting with hypotrichosis and lacrimal obstruction
- Intravenous gentamicin therapy induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients: An open label clinical trial
- iscorEB-p: A patient-reported outcome measure for Epidermolysis bullosa. Psychometric properties of the Patient Score from the Instrument for Scoring Clinical Outcome of Research for EB
- Junctional Epidermolysis Bullosa Linked to Homozygous Mutation in LAMC2 Gene: A Case Report With Eosinophil-Rich Inflammatory Infiltrate
- Laryngo-Onycho-Cutaneous Syndrome (LOCS)
- Lentiviral expression of wild-type LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa
- Lentiviral expression of wildtype LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa
- Lipid Nanoparticles Efficiently Deliver the Base Editor ABE8e for COL7A1 Correction in Dystrophic Epidermolysis Bullosa Fibroblasts In Vitro
- Localized epidermolysis bullosa simplex caused by a previously unreported substitution in the linker 12 domain of keratin 14
- Management of Skin Lesions in Patients with Epidermolysis Bullosa by Topical Treatment: Systematic Review and Meta-Analysis
- Measuring the impact of pruritus in patients with epidermolysis bullosa: evaluation with an itch-specific instrument
- Methods for Decreasing Preweaning Mortality in a Fragile Mouse Model of Hypomorphic Collagen VII Deficiency
- Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications
- Neonatal Epidermolysis Bullosa: a clinical practice guideline
- Nephrotic syndrome: Pretibial epidermolysis bullosa in a patient with <em>CD151</em> tetraspanin defect: A case report
- Nonsense variant readthrough therapy for epidermolysis bullosa
- Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa
- Of LAMA3 and LAMB3: A novel gene therapy for epidermolysis bullosa
- On- and off-target effects of paired CRISPR-Cas nickase in primary human cells
- Orofacial Anomalies in Kindler Epidermolysis Bullosa
- Osteoporosis and bone health in pediatric patients with epidermolysis bullosa: A scoping review
- Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study
- Phenotypic differences in intermediate generalized junctional epidermolysis bullosa with homozygous LAMC2 mutation and a potential genetic modifier
- Practical guide for epidermolysis bullosa management in the first 4 weeks of life
- Practical Tips on Epidermolysis Bullosa for Caregivers: Part 2
- Pregnancy-associated blistering in a patient with junctional epidermolysis bullosa
- Pruritus Anesis in Dystrophic Epidermolysis Bullosa Pruriginosa with Dupilumab
- Recent and anticipated novel drug approvals for 2024
- Rituximab in the Management of Autoimmune Bullous Diseases: A Treatment-Resistant Case Series from a Single Central European Referral Center
- Scarring alopecia and nail loss in a patient with epidermolysis bullosa acquisita
- Self-improving dystrophic epidermolysis bullosa with a novel heterozygous missense variant in the COL7A1 gene in a Taiwanese family
- Simple and affordable soft brace application in dystrophic epidermolysis bullosa patients
- Skin Microbial Composition and Genetic Mutation Analysis in Precision Medicine for Epidermolysis Bullosa
- Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa
- Stop codon readthrough as a treatment option for epidermolysis bullosa-Where we are and where we are going
- Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
- Subepidermal blistering disease presenting with anti-p200 and anti-type VII collagen autoantibodies
- Successful treatment of multicentric Castleman's disease associated with dystrophic epidermolysis bullosa using anti-interleukin-6 receptor antibody
- Sustained clinical remission for 5 years in severe epidermolysis bullosa acquisita following rituximab infusions
- Th2 response drives itch in dystrophic epidermolysis bullosa pruriginosa: a case-control study
- The Need of Differential Diagnosis Between Vulvar Lichen Sclerosus and Autoimmune Dermatoses in Adolescent Girls
- Totally endoscopic concomitant aortic and mitral valve surgery in junctional epidermolysis bullosa: a case report
- Translation, cultural adaptation and validation of the German Quality of life in Epidermolysis Bullosa (QOLEB) questionnaire
- U-Serrated and N-Serrated Patterns in Bullous Pemphigoid, Epidermolysis Bullosa Acquisita, and Bullous Lupus: A Retrospective Observational Study